KPIs & Operating Metrics(New)

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Accured Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Twist Bioscience (TWST) Long-Term Debt Repayments (2019 - 2022)

Twist Bioscience has reported Long-Term Debt Repayments over the past 4 years, most recently at $3.1 million for Q2 2022.

Quarterly Long-Term Debt Repayments rose 274.07% to $3.1 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Mar 2023, up 2785.19% year-over-year, with the annual reading at $1.6 million for FY2022, 53.26% down from the prior year.
Long-Term Debt Repayments was $3.1 million for Q2 2022 at Twist Bioscience, up from -$11.6 million in the prior quarter.
Over five years, Long-Term Debt Repayments peaked at $10.0 million in Q4 2021 and troughed at -$11.6 million in Q1 2022.
The 4-year median for Long-Term Debt Repayments is $833000.0 (2019), against an average of $760846.2.
Year-over-year, Long-Term Debt Repayments surged 1300.48% in 2021 and then crashed 562.32% in 2022.
A 4-year view of Long-Term Debt Repayments shows it stood at $833000.0 in 2019, then tumbled by 200.0% to -$833000.0 in 2020, then surged by 1300.48% to $10.0 million in 2021, then crashed by 68.84% to $3.1 million in 2022.
Per Business Quant, the three most recent readings for TWST's Long-Term Debt Repayments are $3.1 million (Q2 2022), -$11.6 million (Q1 2022), and $10.0 million (Q4 2021).